Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.3.2' and the previous 'Revision: v3.3.1' label appears to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedMinor revision update from v3.2.0 to v3.3.1 with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoval of the government funding status banner; core study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.3%

- Check43 days agoChange DetectedThe screenshots show the same Study Details page with no substantive changes to core study information (title, conditions, endpoints, eligibility, enrollment, locations); only visual layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedMajor update: system notice about funding/operating status and a version bump to v3.2.0 (replacing v3.1.0).SummaryDifference3%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.